CCL2 and neoplasm: On the contrary there was an increase in the Th2 mediators IL-4, IL-6, IL-27, soluble chemokine ligands and pro-inflammatory mediators responsible for promoting pro-tumor immune cells; MCP-1, and IL-16 (Figure 5).